|
Mechanismfibrin modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
DBT用于肝脏/脾脏/胰腺切除手术时止血作用的I/II期探索性临床试验
[Translation] Phase I/II exploratory clinical trial of DBT for hemostasis during liver/spleen/pancreas resection
初步评价DBT用于肝脏/脾脏/胰腺切除术止血时的有效性和安全性
[Translation] Preliminary evaluation of the effectiveness and safety of DBT for hemostasis during liver/spleen/pancreas resection
100 Clinical Results associated with Guangzhou Baitejing Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Guangzhou Baitejing Pharmaceutical Technology Co., Ltd.
100 Deals associated with Guangzhou Baitejing Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Guangzhou Baitejing Pharmaceutical Technology Co., Ltd.